62 related articles for article (PubMed ID: 17425201)
1. Thin-layer cytology: identification of human papillomavirus by hybridization, capture and signal amplification assay using an alcoholic cell preservative medium.
Hammou JC
Acta Cytol; 2007; 51(2):193-6. PubMed ID: 17425201
[TBL] [Abstract][Full Text] [Related]
2. HPV testing in liquid cytology specimens: comparison of analytic sensitivty and specificity for in situ hybridization and chemiluminescent nucleic acid testing.
Qureshi MN; Bolick D; Ringer PJ; Spagler FL; Zimmerman G
Acta Cytol; 2005; 49(2):120-6. PubMed ID: 15839613
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fluorescence in situ hybridization, hybrid capture 2 and polymerase chain reaction for the detection of high-risk human papillomavirus in cervical cytology specimens.
Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
Anal Quant Cytol Histol; 2009 Aug; 31(4):208-16. PubMed ID: 19736868
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
[TBL] [Abstract][Full Text] [Related]
5. Detecting high-risk human papillomavirus in liquid-based cytology specimens.
Qureshi MN
Acta Cytol; 2005; 49(5):582. PubMed ID: 16334042
[No Abstract] [Full Text] [Related]
6. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
7. [Spontaneous clearance of high risk human papillomavirus infection].
Zhang WY; Ma CB; Xiao JY; Zhou HR
Zhonghua Fu Chan Ke Za Zhi; 2010 Jul; 45(7):515-8. PubMed ID: 21029604
[TBL] [Abstract][Full Text] [Related]
8. [Study for association between high risk human papillomavirus and cervical lesions in the samples from opportunistic screening].
Bian LH; Li Y; Wang XL; Wu XZ; Song L; Liu HT
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):89-91. PubMed ID: 21863625
[TBL] [Abstract][Full Text] [Related]
9. Clinical laboratory evaluation of Invader® chemistry and hybrid capture for detection of high-risk human papillomavirus in liquid-based cytology specimens.
Munson E; Du Chateau BK; Bellerose B; Czarnecka J; Griep J
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):230-5. PubMed ID: 21899977
[TBL] [Abstract][Full Text] [Related]
10. HPV testing in cervical cytology practice: it's all about choice.
Stoler MH
Acta Cytol; 2005; 49(2):117-9. PubMed ID: 15839612
[No Abstract] [Full Text] [Related]
11. The impact of high risk human papillomavirus testing in an inner London colposcopy clinic.
Perrons C; Brink N; Jalal H; Watts P; Jelley R
J Med Virol; 2005 Aug; 76(4):576-82. PubMed ID: 15977240
[TBL] [Abstract][Full Text] [Related]
12. Universal Collection Medium (UCM) is as suitable as the Standard Transport Medium (STM) for Hybrid Capture II (HC-2) assay.
Taha NS; Focchi J; Ribalta JC; Castelo A; Lorincz A; Dôres GB
J Clin Virol; 2006 May; 36(1):32-5. PubMed ID: 16483839
[TBL] [Abstract][Full Text] [Related]
13. Stability of PreservCyt for Hybrid Capture (HC II) HPV test.
Sailors J; Gander R; Saboorian MH; Berkley P; Foster B; Ashfaq R
Diagn Cytopathol; 2005 May; 32(5):260-3. PubMed ID: 15830373
[TBL] [Abstract][Full Text] [Related]
14. Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.
Seme K; Lepej SZ; Lunar MM; Iscić-Bes J; Planinić A; Kocjan BJ; Vince A; Poljak M
J Clin Virol; 2009 Oct; 46(2):176-9. PubMed ID: 19683958
[TBL] [Abstract][Full Text] [Related]
15. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
[TBL] [Abstract][Full Text] [Related]
16. AgarCyto: a novel cell-processing method for multiple molecular diagnostic analyses of the uterine cervix.
Kerstens HM; Robben JC; Poddighe PJ; Melchers WJ; Boonstra H; de Wilde PC; Macville MV; Hanselaar AG
J Histochem Cytochem; 2000 May; 48(5):709-18. PubMed ID: 10769055
[TBL] [Abstract][Full Text] [Related]
17. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV.
Guillaud M; Adler-Storthz K; Malpica A; Staerkel G; Matisic J; Van Niekirk D; Cox D; Poulin N; Follen M; Macaulay C
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S16-23. PubMed ID: 16188299
[TBL] [Abstract][Full Text] [Related]
18. Detection of high-risk human papillomavirus by two molecular techniques: hybrid capture and linear array.
de Antonio JC; Fernández-Olmos A; Mercadillo M; Lindemann ML; Mochales FB
J Virol Methods; 2008 Apr; 149(1):163-6. PubMed ID: 18328575
[TBL] [Abstract][Full Text] [Related]
19. Cell Block Preparation versus Liquid-Based Thin-Layer Cervical Cytology: A Comparative Study Evaluating Human Papillomavirus Testing by Hybrid Capture-2/Cervista, in situ Hybridization and p16 Immunohistochemistry.
Tawfik O; Davis M; Diaz FJ; Fan F
Acta Cytol; 2016; 60(2):145-53. PubMed ID: 27215562
[TBL] [Abstract][Full Text] [Related]
20. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
